Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients Caregivers Providers
Log In Ask a Question
PubMed This is a summary of 20 peer-reviewed journal articles Updated
Gastroenterology

Your Lifelong Roadmap: Monitoring and Surveillance

At a Glance

Lifelong monitoring is essential for individuals with Familial Adenomatous Polyposis (FAP) to prevent cancer. Surveillance typically includes annual colonoscopies starting in childhood, upper endoscopies graded by the Spigelman system, and ongoing post-surgery checks of the digestive tract.

Living with Familial Adenomatous Polyposis (FAP) means committing to a lifelong “roadmap” of medical surveillance. While the frequency of these tests can feel burdensome, they are the tools that allow you and your care team to stay ahead of the condition [1][2]. Even after the colon is removed, monitoring continues because the APC mutation still exists in the remaining tissues of your digestive tract and other organs [3][4].

Your Surveillance Roadmap

The timing of your screenings depends largely on whether you have Classic FAP or Attenuated FAP (AFAP), as well as whether you have already had surgery [1][5].

While the idea of a lifetime of endoscopies and colonoscopies sounds torturous, it is important to know that these procedures are typically performed under “twilight” sedation or anesthesia. This means you will be comfortable, relaxed, and often completely unaware of the procedure while it happens.

Before Surgery: Monitoring the Colon

  • Classic FAP: Colonoscopies typically begin between ages 10 and 15 [1][6]. These are usually performed every year to track polyp growth and determine the best time for surgery [1].
  • AFAP: Because polyps appear later in the attenuated form, screening often starts in the late teens or early twenties (ages 18–20) [1][5]. These may be spaced every 1 to 3 years depending on what the doctor finds [1][7].

The Upper GI Tract: Spigelman Staging

The duodenum (the first part of the small intestine) is the most common place for polyps after the colon [1][8]. Screening with an upper endoscopy (EGD) usually starts around age 25 [8][9].

Doctors use the Spigelman Staging System to grade the severity of duodenal polyps based on their number, size, and type [10][11]. This score determines your next step:

  • Stage I-II: Lower risk; surveillance every 3 to 5 years [9][8].
  • Stage III: Moderate risk; surveillance every 6 to 12 months [9].
  • Stage IV: High risk. At this stage, your doctor may recommend surgery to prevent small bowel cancer [9][12]. It is critical to understand that surgery for the duodenum (such as a Whipple procedure or a pancreas-sparing duodenectomy) is a massive, highly complex operation that carries significant risks and must be performed at a highly specialized surgical center.

Monitoring After Surgery

Surgery removes the primary cancer risk, but it does not end the need for scopes. Tiny amounts of at-risk tissue always remain [3][4].

  • If you have a J-Pouch (IPAA): Doctors must monitor the “pouch” and the rectal cuff (the small area where the pouch is attached) for new polyps [13][14]. This is typically done every 1 to 2 years [15][13].
  • If you have a Rectal Remnant (IRA): Because the entire rectum is still present, the risk of cancer remains high. You will likely need a scope every 6 to 12 months to remove any new polyps [3][16].

Lifelong Body Checks

Beyond the digestive tract, your care team will monitor for other manifestations [2][1]:

  • Thyroid: Annual or biennial thyroid ultrasounds are recommended, especially for women, starting in their 20s to watch for a specific type of FAP-related thyroid cancer [17][18].
  • Desmoid Tumors: While there isn’t a standard “scan” for everyone, your doctor will perform regular physical exams (feeling the abdomen) and may order an MRI or CT scan if you develop pain or a noticeable lump [19][20].

Managing the Burden

It is normal to feel “scanxiety”—the intense emotional stress that builds up before a scheduled screening or while waiting for results. FAP can feel isolating, but you do not have to carry the emotional burden alone. Many patients find it incredibly helpful to seek out psychosocial support, such as a specialized therapist, or to connect with patient advocacy groups. Talking with others who have faced J-pouch surgery or lifelong monitoring can be life-changing.

To help you feel more in control of your journey, keep a dedicated folder or digital log of your Spigelman stages and biopsy results [7][15].

FAP Surveillance Cheat Sheet

Area Monitored When to Start Frequency Test Used
Colon (Classic FAP) Age 10-15 Every 1 year Colonoscopy
Colon (AFAP) Age 18-20 Every 1 to 3 years Colonoscopy
Upper GI (Duodenum) Age 25 Based on Spigelman Stage (Every 6 mos to 5 yrs) Upper Endoscopy (EGD)
J-Pouch Post-Surgery Every 1 to 2 years Pouchoscopy
Rectal Remnant (IRA) Post-Surgery Every 6 to 12 months Flexible Sigmoidoscopy
Thyroid Late teens / 20s Every 1 to 2 years Ultrasound

Common questions in this guide

When should colonoscopy screenings begin for FAP?
For Classic FAP, colonoscopies typically begin between ages 10 and 15 and are performed annually. For Attenuated FAP (AFAP), screening often starts in the late teens or early twenties and may be spaced out every 1 to 3 years depending on findings.
Do I still need monitoring after my colon is removed?
Yes, you will still need regular screenings. Because tiny amounts of at-risk tissue always remain, doctors must regularly monitor your J-pouch or rectal remnant for new polyps using a pouchoscopy or flexible sigmoidoscopy.
What is the Spigelman Staging System?
The Spigelman Staging System is a tool doctors use to grade the severity of polyps in the duodenum based on their number, size, and type. This score dictates how often you need an upper endoscopy, ranging from every few years for lower stages to every 6 months for higher stages.
What other organs need to be monitored if I have FAP?
In addition to the digestive tract, your care team will monitor your thyroid with regular ultrasounds starting in your 20s to watch for a specific type of thyroid cancer. Your doctor will also perform regular physical exams to check the abdomen for desmoid tumors.
Will my lifelong colonoscopies and endoscopies be painful?
These procedures are typically performed under 'twilight' sedation or general anesthesia. This means you will be comfortable, relaxed, and often completely unaware of the procedure while it is happening.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on my last upper endoscopy, what is my Spigelman score, and how does it change how often I need to come back?
  2. 2.Since I have a J-pouch (or rectal remnant), what specifically are you looking for during my annual scope, and how do you handle any new polyps found there?
  3. 3.Should I be having a thyroid ultrasound every year, or is every two years sufficient for my risk level?
  4. 4.Are there specific symptoms of desmoid tumors I should be watching for between my scheduled imaging or exams?
  5. 5.Can we create a written 'surveillance calendar' so I can track my upcoming screenings for the next five years?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (20)
  1. 1

    Updated European guidelines for clinical management of familial adenomatous polyposis (FAP), MUTYH-associated polyposis (MAP), gastric adenocarcinoma, proximal polyposis of the stomach (GAPPS) and other rare adenomatous polyposis syndromes: a joint EHTG-ESCP revision.

    Zaffaroni G, Mannucci A, Koskenvuo L, et al.

    The British journal of surgery 2024; (111(5)) doi:10.1093/bjs/znae070.

    PMID: 38722804
  2. 2

    Recent trends in the morbidity and mortality in patients with familial adenomatous polyposis: a retrospective single institutional study in Japan.

    Mori Y, Amano K, Chikatani K, et al.

    International journal of clinical oncology 2022; (27(6)):1034-1042 doi:10.1007/s10147-022-02146-4.

    PMID: 35274183
  3. 3

    Long-term outcomes of metachronous neoplasms in the ileal pouch and rectum after surgical treatment in patients with familial adenomatous polyposis.

    Tajika M, Tanaka T, Ishihara M, et al.

    Endoscopy international open 2019; (7(5)):E691-E698 doi:10.1055/a-0849-9465.

    PMID: 31073536
  4. 4

    Endoscopic management of patients with familial adenomatous polyposis after prophylactic colectomy or restorative proctocolectomy - systematic review of the literature.

    Gavric A, Sanchez LR, Brunori A, et al.

    Radiology and oncology 2024; (58(2)):153-169 doi:10.2478/raon-2024-0029.

    PMID: 38860690
  5. 5

    Attenuated adenomatous polyposis of the large bowel: Present and future.

    Roncucci L, Pedroni M, Mariani F

    World journal of gastroenterology 2017; (23(23)):4135-4139 doi:10.3748/wjg.v23.i23.4135.

    PMID: 28694653
  6. 6

    Targeted next-generation sequencing approach for molecular genetic diagnosis of hereditary colorectal cancer: Identification of a novel single nucleotide germline insertion in adenomatous polyposis coli gene causes familial adenomatous polyposis.

    Wang D, Liang S, Zhang X, et al.

    Molecular genetics & genomic medicine 2019; (7(1)):e00505 doi:10.1002/mgg3.505.

    PMID: 30523670
  7. 7

    Attenuated Familial Adenomatous Polyposis: A Phenotypic Diagnosis but Obsolete Term?

    Anele CC, Martin I, McGinty Duggan PM, et al.

    Diseases of the colon and rectum 2022; (65(4)):529-535 doi:10.1097/DCR.0000000000002217.

    PMID: 34775416
  8. 8

    Frequency and Features of Duodenal Adenomas in Patients With MUTYH-Associated Polyposis.

    Walton SJ, Kallenberg FG, Clark SK, et al.

    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2016; (14(7)):986-92.

    PMID: 26905905
  9. 9

    Endoscopic management of duodenal adenomatosis in familial adenomatous polyposis-A case-based review.

    Soons E, Bisseling TM, van Kouwen MCA, et al.

    United European gastroenterology journal 2021; (9(4)):461-468 doi:10.1002/ueg2.12071.

    PMID: 34529357
  10. 10

    Validation of the Endoscopic Part of the Spigelman Classification for Evaluating Duodenal Adenomatosis in Familial Adenomatous Polyposis: A Prospective Study of Interrater and Intrarater Reliability.

    Karstensen JG, Bülow S, Burisch J, et al.

    The American journal of gastroenterology 2022; (117(2)):343-345 doi:10.14309/ajg.0000000000001582.

    PMID: 34913876
  11. 11

    The impact of chromoendoscopy for surveillance of the duodenum in patients with MUTYH-associated polyposis and familial adenomatous polyposis.

    Hurley JJ, Thomas LE, Walton SJ, et al.

    Gastrointestinal endoscopy 2018; (88(4)):665-673 doi:10.1016/j.gie.2018.04.2347.

    PMID: 29702101
  12. 12

    Impact of Endoscopic Treatment in Severe Duodenal Polyposis: A National Study in Familial Adenomatous Polyposis Patients.

    Le Bras P, Cauchin E, De Lange G, et al.

    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2024; (22(9)):1839-1846.e1 doi:10.1016/j.cgh.2024.03.007.

    PMID: 38555039
  13. 13

    Histopathological Evaluation of Pouch Neoplasia in IBD and Familial Adenomatous Polyposis.

    Ko HM

    Diseases of the colon and rectum 2024; (67(S1)):S91-S98 doi:10.1097/DCR.0000000000003320.

    PMID: 38422398
  14. 14

    Dysplasia at the Anal Transition Zone after IPAA.

    Church J

    Clinics in colon and rectal surgery 2022; (35(6)):495-498 doi:10.1055/s-0042-1758228.

    PMID: 36591401
  15. 15

    Incidence and Risk Factors of Cancer in the Anal Transitional Zone and Ileal Pouch following Surgery for Ulcerative Colitis and Familial Adenomatous Polyposis.

    Le Cosquer G, Buscail E, Gilletta C, et al.

    Cancers 2022; (14(3)) doi:10.3390/cancers14030530.

    PMID: 35158797
  16. 16

    Risk of Rectal Neoplasia after Colectomy and Ileorectal Anastomosis for Ulcerative Colitis.

    Uzzan M, Kirchgesner J, Oubaya N, et al.

    Journal of Crohn's & colitis 2017; (11(8)):930-935 doi:10.1093/ecco-jcc/jjx027.

    PMID: 28333202
  17. 17

    Prevalence of and risk factors for thyroid carcinoma in patients with familial adenomatous polyposis: results of a multicenter study in Japan and a systematic review.

    Sada H, Hinoi T, Ueno H, et al.

    Surgery today 2019; (49(1)):72-81 doi:10.1007/s00595-018-1710-3.

    PMID: 30182306
  18. 18

    Clinicopathological and molecular mechanisms of cribriform morular thyroid carcinoma: a case report and a literature review.

    Zhang X, Lv Y, Yan W, et al.

    Annals of medicine and surgery (2012) 2025; (87(12)):8944-8948 doi:10.1097/MS9.0000000000004082.

    PMID: 41377377
  19. 19

    Adenomatous Polyposis Coli Gene Mutations, Risk Factors, and Long-term Outcomes Associated With Desmoid Tumors in Patients With Familial Adenomatous Polyposis After Colectomy in Japan.

    Kojima T, Kurachi K, Iwaizumi M, et al.

    Journal of clinical gastroenterology 2025; (59(7)):583-591 doi:10.1097/MCG.0000000000002071.

    PMID: 39729982
  20. 20

    Current management of familial adenomatous polyposis.

    Lauricella S, Rausa E, Pellegrini I, et al.

    Expert review of anticancer therapy 2024; (24(6)):363-377 doi:10.1080/14737140.2024.2344649.

    PMID: 38785081

This page provides general FAP surveillance and screening guidelines for educational purposes. Always consult your gastroenterologist or surgical team for a personalized screening schedule tailored to your specific diagnosis and medical history.

Get notified when new evidence is published on Familial Adenomatous Polyposis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.